ORBIMED ADVISORS LLC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:30 pm Purchase | 2024-12-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ORBIMED ADVISORS LLC | 718,200 5.900% | 129,000 (+21.89%) | Filing |
| 2024-11-14 6:41 pm Purchase | 2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ORBIMED ADVISORS LLC | 589,200 4.900% | 589,200 (New Position) | Filing |